The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease
Abstract
Clinical trials require valid outcome measures to assess the therapeutic benefit of investigational agents. Recently, regulatory authorities have mandated the use of patient-reported outcomes in combination with an objective measure of disease activity as primary outcome measures in inflammatory bowel disease trials. Endoscopy has commonly fulfilled the latter role; however, due to the costs and complexity of these assessments, interest has...
Paper Details
Title
The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease
Published Date
May 28, 2018
Journal
Volume
24
Issue
8
Pages
1619 - 1623
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History